These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2151757)

  • 1. Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist.
    Gore S; Gilmore IT; Haigh CG; Brownless SM; Stockdale H; Morris AI
    Aliment Pharmacol Ther; 1990 Apr; 4(2):139-44. PubMed ID: 2151757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.
    Talley NJ; Phillips SF; Haddad A; Miller LJ; Twomey C; Zinsmeister AR; MacCarty RL; Ciociola A
    Dig Dis Sci; 1990 Apr; 35(4):477-80. PubMed ID: 2138532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
    Kadowaki M; Nagakura Y; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 Jul; 266(1):74-80. PubMed ID: 8331576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig.
    Costall B; Gunning SJ; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Jun; 91(2):263-4. PubMed ID: 2955843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers.
    Houghton LA; Foster JM; Whorwell PJ
    Aliment Pharmacol Ther; 2000 Jun; 14(6):775-82. PubMed ID: 10848662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study.
    Steadman CJ; Talley NJ; Phillips SF; Zinsmeister AR
    Mayo Clin Proc; 1992 Aug; 67(8):732-8. PubMed ID: 1434911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oral cisapride on colonic transit.
    Krevsky B; Malmud LS; Maurer AH; Somers MB; Siegel JA; Fisher RS
    Aliment Pharmacol Ther; 1987 Aug; 1(4):293-304. PubMed ID: 2979674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.
    Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luminally released serotonin stimulates colonic motility and accelerates colonic transit in rats.
    Tsukamoto K; Ariga H; Mantyh C; Pappas TN; Yanagi H; Yamamura T; Takahashi T
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R64-9. PubMed ID: 17442783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
    Koulu M; Lappalainen J; Hietala J; Sjöholm B
    Psychopharmacology (Berl); 1990; 101(2):168-71. PubMed ID: 2140903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of mucosal 5-HT3 receptors is involved in restoration of colonic transit after pelvic nerve transection.
    Gribovskaja-Rupp I; Takahashi T; Ridolfi T; Kosinski L; Ludwig K
    Neurogastroenterol Motil; 2012 May; 24(5):472-8, e218. PubMed ID: 22304456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.
    Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M
    J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers.
    Poen AC; Felt-Bersma RJ; Van Dongen PA; Meuwissen SG
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1493-7. PubMed ID: 10571606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The function of 5-HT3 receptors on colonic transit in rats.
    Haga K; Asano K; Fukuda T; Kobayakawa T
    Obes Res; 1995 Dec; 3 Suppl 5():801S-810S. PubMed ID: 8653566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects.
    Degen L; Matzinger D; Merz M; Appel-Dingemanse S; Osborne S; Lüchinger S; Bertold R; Maecke H; Beglinger C
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1745-51. PubMed ID: 11683688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowing of intestinal transit by fat depends on an ondansetron - sensitive, efferent serotonergic pathway.
    Lin HC; Chen JH
    Neurogastroenterol Motil; 2003 Jun; 15(3):317-22. PubMed ID: 12787341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ondansetron on gastric emptying in the conscious rat.
    Forster ER; Dockray GJ
    Eur J Pharmacol; 1990 Nov; 191(2):235-8. PubMed ID: 2150819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms underlying the laxative effect of lactulose: A randomized placebo-controlled trial showing increased small bowel water and motility unaltered by the 5-HT
    Gunn D; Yeldho C; Hoad C; Menys A; Gowland P; Marciani L; Spiller R
    Neurogastroenterol Motil; 2024 Apr; 36(4):e14754. PubMed ID: 38316636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of GK-128 [2-[(2-methylimidazol-1-yl)methyl]-benzo[f]thiochromen-1-one monohydrochloride hemihydrate], a selective 5-hydroxytryptamine3 receptor antagonist, on colonic function in rats.
    Ito C; Isobe Y; Kawamura R; Kiuchi Y; Tsuchida K; Higuchi S
    J Pharmacol Exp Ther; 1997 Jan; 280(1):67-72. PubMed ID: 8996183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascending colon response to feeding: evidence for a 5-hydroxytryptamine-3 mechanism.
    Scolapio JS; Camilleri M; von der Ohe MR; Hanson RB
    Scand J Gastroenterol; 1995 Jun; 30(6):562-7. PubMed ID: 7569764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.